neobookRx

Massive Transfusion Protocol

Description Major haemorrhage may be defined as blood loss >150 ml/min, loss of >50% of blood volume in 3 hours, or loss of entire blood volume in 24 hours. A massive transfusion may also be defined by the transfusion of >4 units of red blood cells in 1 hour, replacement of >50% of blood volume in 3 hours (>5 units in 3 hours), or the replacement of entire blood volume in 24 hours

Description

Major haemorrhage may be defined as blood loss >150 ml/min, loss of >50% of blood volume in 3 hours, or loss of entire blood volume in 24 hours.

A massive transfusion may also be defined by the transfusion of >4 units of red blood cells in 1 hour, replacement of >50% of blood volume in 3 hours (>5 units in 3 hours), or the replacement of entire blood volume in 24 hours (>10 units in 24 hours).

LoE:IVbxxvii

In the setting of major haemorrhage, blood and blood products are most efficiently and effectively administered using a massive transfusion protocol (MTP).

Essentials of the protocol:

  • The massive transfusion protocol is designed to facilitate the transfusion of large volumes of blood (at least 6 units of red blood cells) and blood products.
  • MTP aims to avoid acute coagulopathy in major haemorrhage that is associated with trauma and other causes during the resuscitation phase.
  • Blood components are given in fixed ratios initially. Further blood product administration is ideally guided by point of care coagulation testing.
  • An MTP should be a collaboration between the treating unit/institution and the providing blood service. The exact details of the protocol will differ depending on the specifics of the treating unit/institution (See Figure 23.1 below for an example of a massive transfusion protocol).

Massive Transfusion Protocol Approach

Click on the image to enlarge

Click here for the pdf

Click here for the circular


Standard Treatment Guidelines and Essential Medicines List for South Africa Adult Hospital _Chapter 23: Adult Critical Care_NEMLC Medicine Recommendations Review Cycle_ 2020_2023

NeoHealth® ID 36452 · updated 7/3/2024